Genomtec
Genomtec develops mobile platforms for genetic diagnostics at the point of patient care using proprietary SNAAT technology. The company's primary products include the Genomtec ID, a respiratory panel for detecting viruses and bacteria, and OncoSNAAT for oncology applications. These diagnostic tools are designed for use in clinical laboratories and by healthcare providers to provide rapid molecular testing.
Healthtech
Biotechnology
Diagnostics
Medical Devices
Funding summary
- Total raised
- €17.5M
- Funding rounds
- 5
Investors in Genomtec
Investors on record for Genomtec. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Genomtec?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors